Chesley Taft & Associates LLC Astrazeneca PLC Transaction History
Chesley Taft & Associates LLC
- $2.13 Billion
- Q4 2024
A detailed history of Chesley Taft & Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 3,400 shares of AZN stock, worth $226,439. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,400
Previous 16,525
79.43%
Holding current value
$226,439
Previous $1.29 Million
82.75%
% of portfolio
0.01%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.19 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.8 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...